Oridion Systems (SIX Swiss Exchange: ORIDN) develops technology for the detection and measurement of carbon dioxide (CO2) in exhaled breath. This is used for capnography, which monitors a patient's ventilatory status, and for the non-invasive diagnosis and monitoring of various conditions in specific internal organs.
Exit: Oridion carried out an IPO on the SWX Swiss Exchange (now the SIX Swiss Exchange) in April 2000, when it raised $77M. Gemini no longer invests in medical device companies.
Location: United States, Massachusetts, Needham
Investors 1
| Date | Name | Website |
| - | Gemini Isr... | gemini.co.... |
Mentions in press and media 3
| Date | Title | Description | Source |
| 20.01.2012 | Oridion can resume importing most of its medical devices int... | Oridion Systems Ltd. (PINK:ORDNF) can resume importing medical devices into the U.S., after the FDA ... | massdevice... |
| 02.01.2012 | FDA bans Oridion imports, share prices dive 40% | The FDA banned Oridion Systems Ltd. (PINK:ORDNF) from importing any medical devices into the U.S., a... | massdevice... |
| 19.10.2011 | Oridion gets FDA warning on Israeli manufacturing facility | Oridion Systems Ltd. (SWF:ORIDN) is in the FDA spotlight for violations at its Jerusalem, Israel, ma... | massdevice... |